We've found
					10,842 Neurology				
					clinical trials				
				
			
		
							
  	
	Duchenne Muscular Dystrophy Clinical Trial
	Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Duchenne Muscular Dystrophy Clinical Trial
	Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Duchenne Muscular Dystrophy Clinical Trial
	Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Psychiatry / Psychology, Other Clinical Trial
	Hyperbaric Oxygen Therapy in Chronic Traumatic Brain Injury or Post-Traumatic Stress Disorder
		Status: Enrolling	
	
	
			Updated: 4/22/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Acute Ischemic Stroke Clinical Trial
	Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
		Status: Enrolling	
	
	
			Updated: 7/31/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Acute Ischemic Stroke Clinical Trial
	Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
		Status: Enrolling	
	
	
			Updated: 7/31/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Acute Ischemic Stroke Clinical Trial
	Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
		Status: Enrolling	
	
	
			Updated: 7/31/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Stroke, Acute Clinical Trial
	The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 6/3/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Stroke, Acute Clinical Trial
	The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 6/3/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Multiple Sclerosis Clinical Trial
	Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
		Status: Enrolling	
	
	
			Updated: 11/9/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Multiple Sclerosis Clinical Trial
	Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
		Status: Enrolling	
	
	
			Updated: 11/9/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Multiple Sclerosis Clinical Trial
	Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
		Status: Enrolling	
	
	
			Updated: 11/9/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Other, Reproductive Clinical Trial
	Prevention of Photoparoxysmal Abnormalities by Mozart K448
		Status: Enrolling	
	
	
			Updated: 5/27/2011	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Orthopedics / Podiatry, Other Clinical Trial
	Microelectrode Brain-Machine Interface for Individuals With Tetraplegia
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Autism Spectrum Disorders Clinical Trial
	Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 3/21/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dystonia Clinical Trial
	The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Neurology Clinical Trial
	Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Neurology Clinical Trial
	Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hematology, Neurology Clinical Trial
	Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Traumatic Brain Injury Clinical Trial
	Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Cervical Radiculopathy Clinical Trial
	Conservative Therapy Versus Epidural Steroids for Cervical Radiculopathy
		Status: Enrolling	
	
	
			Updated: 4/4/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hereditary Hemorrhagic Telangiectasia Clinical Trial
	Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hereditary Hemorrhagic Telangiectasia Clinical Trial
	Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Hereditary Hemorrhagic Telangiectasia Clinical Trial
	Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Atopic Dermatitis Clinical Trial
	Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Traumatic Brain Injury Clinical Trial
	A Pilot Study to Identify Biomarkers Associated With Chronic Traumatic Brain Injury
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Charcot Marie Tooth Disease Clinical Trial
	Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Charcot Marie Tooth Disease Clinical Trial
	Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dental / Maxillofacial Surgery, Neurology Clinical Trial
	Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dental / Maxillofacial Surgery, Neurology Clinical Trial
	Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Dental / Maxillofacial Surgery, Neurology Clinical Trial
	Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Progressive Multifocal Leukoencephalopathy Clinical Trial
	Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
		Status: Enrolling	
	
	
			Updated: 7/3/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Progressive Multifocal Leukoencephalopathy Clinical Trial
	Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
		Status: Enrolling	
	
	
			Updated: 7/3/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Progressive Multifocal Leukoencephalopathy Clinical Trial
	Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
		Status: Enrolling	
	
	
			Updated: 7/3/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Traumatic Brain Injury Clinical Trial
	Osmotic Therapy for Treatment of Intracranial Hypertension for Traumatic Brain Injury
		Status: Enrolling	
	
	
			Updated: 9/11/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neurology, Oncology Clinical Trial
	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
						
				
			
We've found
					10,842 Neurology
				
					clinical trials
				
				
				
	Duchenne Muscular Dystrophy Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Duchenne Muscular Dystrophy Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Duchenne Muscular Dystrophy Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Psychiatry / Psychology, Other Clinical Trial
	
Updated: 4/22/2014
  
  
  Hyperbaric Oxygen Therapy in Chronic Traumatic Brain Injury or Post-Traumatic Stress Disorder
		Status: Enrolling	
	Updated: 4/22/2014
Click here to add this to my saved trials
	    
		
	Acute Ischemic Stroke Clinical Trial
	
Updated: 7/31/2012
  
  
  Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
		Status: Enrolling	
	Updated: 7/31/2012
Click here to add this to my saved trials
	    
		
	Acute Ischemic Stroke Clinical Trial
	
Updated: 7/31/2012
  
  
  Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
		Status: Enrolling	
	Updated: 7/31/2012
Click here to add this to my saved trials
	    
		
	Acute Ischemic Stroke Clinical Trial
	
Updated: 7/31/2012
  
  
  Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)
		Status: Enrolling	
	Updated: 7/31/2012
Click here to add this to my saved trials
	    
		
	Stroke, Acute Clinical Trial
	
Updated: 6/3/2014
  
  
  The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	Updated: 6/3/2014
Click here to add this to my saved trials
	    
		
	Stroke, Acute Clinical Trial
	
Updated: 6/3/2014
  
  
  The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	Updated: 6/3/2014
Click here to add this to my saved trials
	    
		
	Multiple Sclerosis Clinical Trial
	
Updated: 11/9/2012
  
  
  Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
		Status: Enrolling	
	Updated: 11/9/2012
Click here to add this to my saved trials
	    
		
	Multiple Sclerosis Clinical Trial
	
Updated: 11/9/2012
  
  
  Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
		Status: Enrolling	
	Updated: 11/9/2012
Click here to add this to my saved trials
	    
		
	Multiple Sclerosis Clinical Trial
	
Updated: 11/9/2012
  
  
  Arbaclofen Placarbil for the Treatment of Spasticity in Subjects With Multiple Sclerosis (MS)
		Status: Enrolling	
	Updated: 11/9/2012
Click here to add this to my saved trials
	    
		
	Neurology, Other, Reproductive Clinical Trial
	
Updated: 5/27/2011
  
  
  Prevention of Photoparoxysmal Abnormalities by Mozart K448
		Status: Enrolling	
	Updated: 5/27/2011
Click here to add this to my saved trials
	    
		
	Neurology, Orthopedics / Podiatry, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  Microelectrode Brain-Machine Interface for Individuals With Tetraplegia
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Autism Spectrum Disorders Clinical Trial
	
Updated: 3/21/2016
  
  
  Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 3/21/2016
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dystonia Clinical Trial
	
Updated: 12/31/1969
  
  
  The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hematology, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Traumatic Brain Injury Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Cervical Radiculopathy Clinical Trial
	
Updated: 4/4/2012
  
  
  Conservative Therapy Versus Epidural Steroids for Cervical Radiculopathy
		Status: Enrolling	
	Updated: 4/4/2012
Click here to add this to my saved trials
	    
		
	Hereditary Hemorrhagic Telangiectasia Clinical Trial
	
Updated: 12/31/1969
  
  
  Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hereditary Hemorrhagic Telangiectasia Clinical Trial
	
Updated: 12/31/1969
  
  
  Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Hereditary Hemorrhagic Telangiectasia Clinical Trial
	
Updated: 12/31/1969
  
  
  Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Atopic Dermatitis Clinical Trial
	
Updated: 12/31/1969
  
  
  Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Traumatic Brain Injury Clinical Trial
	
Updated: 12/31/1969
  
  
  A Pilot Study to Identify Biomarkers Associated With Chronic Traumatic Brain Injury
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Charcot Marie Tooth Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Charcot Marie Tooth Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dental / Maxillofacial Surgery, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dental / Maxillofacial Surgery, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Dental / Maxillofacial Surgery, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Progressive Multifocal Leukoencephalopathy Clinical Trial
	
Updated: 7/3/2014
  
  
  Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
		Status: Enrolling	
	Updated: 7/3/2014
Click here to add this to my saved trials
	    
		
	Progressive Multifocal Leukoencephalopathy Clinical Trial
	
Updated: 7/3/2014
  
  
  Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
		Status: Enrolling	
	Updated: 7/3/2014
Click here to add this to my saved trials
	    
		
	Progressive Multifocal Leukoencephalopathy Clinical Trial
	
Updated: 7/3/2014
  
  
  Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
		Status: Enrolling	
	Updated: 7/3/2014
Click here to add this to my saved trials
	    
		
	Traumatic Brain Injury Clinical Trial
	
Updated: 9/11/2012
  
  
  Osmotic Therapy for Treatment of Intracranial Hypertension for Traumatic Brain Injury
		Status: Enrolling	
	Updated: 9/11/2012
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neurology, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials